NO1, a New Sigma 2 Receptor/TMEM97 Fluorescent Ligand, Downregulates SOCE and Promotes Apoptosis in the Triple Negative Breast Cancer Cell Lines. [PDF]
Cantonero C +6 more
europepmc +1 more source
Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands. [PDF]
Floresta G +6 more
europepmc +1 more source
Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury. [PDF]
Vázquez-Rosa E +11 more
europepmc +1 more source
A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease. [PDF]
Grundman M +11 more
europepmc +1 more source
Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex. [PDF]
Riad A +8 more
europepmc +1 more source
S2RSLDB: a comprehensive manually curated, internet-accessible database of the sigma-2 receptor selective ligands. [PDF]
Nastasi G +8 more
europepmc +1 more source
Norbenzomorphan Framework as a Novel Scaffold for Generating Sigma 2 Receptor/PGRMC1 Subtype-Selective Ligands. [PDF]
Sahn JJ, Hodges TR, Chan JZ, Martin SF.
europepmc +1 more source
Related searches:
Sigma-2 Receptor as a Potential Drug Target
Current Medicinal Chemistry, 2021Sigma-2 receptor plays key roles in promoting tumor cell apoptosis, enhancing efficacy of anti-tumor drugs, blocking signal transduction controlled by Aβ oligomers, regulating Ca2+ homeostasis and protecting nerve cells. Studies indicated that sigma-2 receptor may be closely coupled with ROS, LDL, mTOR, RAS, PLC/PKC, lysosomal autophagy and ...
Ai-Fang Chen +3 more
openaire +2 more sources

